General information about company |
| Scrip code* | 544339 |
| NSE Symbol* | LAXMIDENTL |
| MSEI Symbol* | NOTLISTED |
| ISIN* | INE0WO601020 |
| Name of company | LAXMI DENTAL LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 10-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 04-02-2026 |
| Description of presentation currency | INR |
| Level of rounding | Millions |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Integrated Dental Products |
| Start date and time of board meeting | 10-02-2026 16:00 |
| End date and time of board meeting | 10-02-2026 17:33 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | Yes |
| No. of times funds raised during the quarter | 1 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No | It is not applicable for the Quarter ended December 31, 2025. |
Financial Results – Ind-AS |
| Particulars | 3 months/ 6 months ended
(dd-mm-yyyy) | Year to date figures for current period ended
(dd-mm-yyyy) | |
| Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| Whether results are audited or unaudited | Unaudited | Unaudited |
| Nature of report standalone or consolidated | Standalone | Standalone |
| Part I | Blue color marked fields are non-mandatory.
For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. |
| 1 | Income |
| Revenue from operations | 484.51 | 1528.2 | |
| Other income | 20.06 | 60.35 |
| Total income | 504.57 | 1588.55 |
| 2 | Expenses |
| (a) | Cost of materials consumed | 100.34 | 306.6 | |
| (b) | Purchases of stock-in-trade | 53.1 | 176.01 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 2.22 | 19.14 |
| (d) | Employee benefit expense | 200.91 | 570.24 |
| (e) | Finance costs | 2.33 | 5.09 |
| (f) | Depreciation, depletion and amortisation expense | 30.62 | 81.83 |
| (g) | Other Expenses |
| 1 | Other Expenses | 82.3 | 234.19 | |
| Total other expenses | 82.3 | 234.19 |
| Total expenses | 471.82 | 1393.1 |
| 3 | Total profit before exceptional items and tax | 32.75 | 195.45 |
| 4 | Exceptional items | -51.56 | -51.56 |
| 5 | Total profit before tax | -18.81 | 143.89 |
| 6 | Tax expense |
| 7 | Current tax | 18.12 | 58.91 | |
| 8 | Deferred tax | -7.66 | -9.72 |
| 9 | Total tax expenses | 10.46 | 49.19 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 |
| 11 | Net Profit Loss for the period from continuing operations | -29.27 | 94.7 |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 |
| 13 | Tax expense of discontinued operations | 0 | 0 |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | 0 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 10.37 | 30.7 |
| 16 | Total profit (loss) for period | -18.9 | 125.4 |
| 17 | Other comprehensive income net of taxes | -1.52 | -4.26 |
| 18 | Total Comprehensive Income for the period | -20.42 | 121.14 |
| 19 | Total profit or loss, attributable to |
| Profit or loss, attributable to owners of parent | | | |
| Total profit or loss, attributable to non-controlling interests | | |
| 20 | Total Comprehensive income for the period attributable to |
| Comprehensive income for the period attributable to owners of parent | | | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | | |
| 21 | Details of equity share capital |
| Paid-up equity share capital | 109.92 | 109.92 | |
| Face value of equity share capital | 2 | 2 |
| 22 | Reserves excluding revaluation reserve | | |
| 23 | Earnings per share |
| i | Earnings per equity share for continuing operations |
| Basic earnings (loss) per share from continuing operations | -0.34 | 2.28 | |
| Diluted earnings (loss) per share from continuing operations | -0.34 | 2.27 |
| ii | Earnings per equity share for discontinued operations |
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 |
| iii | Earnings per equity share (for continuing and discontinued operations) |
| Basic earnings (loss) per share from continuing and discontinued operations | -0.34 | 2.28 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | -0.34 | 2.27 |
| 24 | Debt equity ratio | | | Textual Information( 1) |
| 25 | Debt service coverage ratio | | | Textual Information( 2) |
| 26 | Interest service coverage ratio | | | Textual Information( 3) |
| 27 | Disclosure of notes on financial results | Textual Information(4) |
Other Comprehensive Income |
| Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| Whether results are audited or unaudited | Unaudited | Unaudited |
| Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |
| 1 | Amount of items that will not be reclassified to profit and loss | |
| 1 | Remeasurement gain/(loss) of net defined benefit plan | -2.03 | -5.69 |
| Total Amount of items that will not be reclassified to profit and loss | -2.03 | -5.69 |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | -0.51 | -1.43 |
| 3 | Amount of items that will be reclassified to profit and loss | |
| Total Amount of items that will be reclassified to profit and loss | | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | | |
| 5 | Total Other comprehensive income | -1.52 | -4.26 |
Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1) |
| Mode of Fund Raising | Public Issues |
| Description of mode of fund raising
(Applicable in case of others is selected) | |
| Date of Raising Funds | 16-01-2025 |
| Amount Raised | 6980.58 |
| Report filed for Quarter ended | 31-12-2025 |
| Monitoring Agency | Applicable |
| Monitoring Agency Name, if applicable | ICRA Limited |
| Is there a Deviation / Variation in use of funds raised | No |
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders | |
| If Yes, Date of shareholder Approval | |
| Explanation for the Deviation / Variation | |
| Comments of the Audit Committee after review | |
| Comments of the auditors, if any | |
| Sr. | Original Object | Modified Object, if any | Original Allocation | Modified allocation, if any | Funds Utilised | Amount of Deviation/Variation for the quarter according to applicable object | Remarks if any |
| 1 | Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our Company | NA | 229.84 | 0 | 229.84 | 0 | |
| 2 | Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings. | NA | 46 | 0 | 46 | 0 | |
| 3 | Funding the capital expenditure requirements for purcahse of new machinery for our company | NA | 435.07 | 0 | 69.73 | 0 | |
| 4 | Investment in our subsidiary Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery | NA | 250.04 | 0 | 3.46 | 0 | |
| 5 | General corporate purposes. | NA | 320.75 | 0 | 320.75 | 0 | |